Brief: Polarityte Announces Positive Top-Line Data From Interim Analysis Of Skinte Diabetic Foot Ulcer Trial

RegenETP,

24/07/2020 13:05

July 24 (Reuters) - PolarityTE Inc  PTE.O :
    * POLARITYTE ANNOUNCES POSITIVE TOP-LINE DATA FROM INTERIM
ANALYSIS OF SKINTE™ DIABETIC FOOT ULCER TRIAL
    * POLARITYTE INC - DEMOGRAPHICS WERE WELL BALANCED BETWEEN
TREATMENT GROUPS WITH NO STATISTICALLY SIGNIFICANT DIFFERENCES
    * POLARITYTE INC - 72% OF PATIENTS TREATED WITH SKINTE PLUS
SOC
ACHIEVED WOUND CLOSURE BY 12 WEEKS VERSUS 32% OF PATIENTS
TREATED WITH SOC ALONE (P=0.005)
    * POLARITYTE INC - NO SIGNIFICANT DIFFERENCES BETWEEN
TREATMENT
GROUPS IN PAIN SCORES, WOUND QUALITY OF LIFE, OR
SEMMES-WEINSTEIN SCORE IN TRIAL
    * POLARITYTE INC - PRELIMINARY ANALYSIS SHOWED THAT SKINTE
TREATMENT DID NOT RESULT IN MORE ADVERSE EVENTS (AES) THAN SOC

Source text for Eikon:  ID:nBw3Qcz3Da 
Further company coverage:  PTE.O 

 ((Reuters.Briefs@thomsonreuters.com;))